Wen-Jen Hwu

2 ta ish

The University of Texas MD Anderson Cancer Center

1. Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients

   Vancheswaran Gopalakrishnan, C. N. Spencer, Luigi Nezi +67

   Maqola20177 iqtibos

   ABIABI:AkademIndex/2026.other.339918

2. A randomized phase III trial of biochemotherapy versus interferon-α-2b for adjuvant therapy in patients at high risk for melanoma recurrence

   Kevin B. Kim, Sewa S. Legha, René González +18

   Maqola20092 iqtibos

   ABIABI:AkademIndex/2026.other.106252